Response of relapsed or refractory primary central nervous system lymphoma (PCNSL) to topotecan
- 25 May 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurology
- Vol. 62 (10) , 1885-1887
- https://doi.org/10.1212/01.wnl.0000125334.16420.d4
Abstract
The authors treated 16 immunocompetent patients with refractory or relapsed primary CNS lymphoma with topotecan. Fifteen patients had been pretreated with up to three chemotherapy regimens, three of them additionally with whole brain irradiation (WBI), and one with WBI alone. Four complete remissions and two partial remissions were achieved. Progression-free survival was 20% at 6 months and 13% at 12 months.Keywords
This publication has 10 references indexed in Scilit:
- Salvage treatment with etoposide (VP‐16), ifosfamide and cytarabine (Ara‐C) for patients with recurrent primary central nervous system lymphomaEuropean Journal of Haematology, 2003
- Treatment of Primary CNS Lymphoma With Methotrexate and Deferred Radiotherapy: A Report of NABTT 96–07Journal of Clinical Oncology, 2003
- Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group ExperienceJournal of Clinical Oncology, 2003
- Response to topotecan of symptomatic brain metastases of small-cell lung cancer also after whole-brain irradiation: a multicentre phase II studyEuropean Journal Of Cancer, 2002
- Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular LymphomaJournal of Clinical Oncology, 2001
- Treatment for Primary CNS Lymphoma: The Next StepJournal of Clinical Oncology, 2000
- PCV salvage chemotherapy for recurrent primary CNS lymphomaNeurology, 2000
- Second-line treatment for primary central nervous system lymphomaBritish Journal of Cancer, 1999
- High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.Journal of Clinical Oncology, 1998
- Combined modality therapy for primary CNS lymphoma.Journal of Clinical Oncology, 1992